Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 13.18% is 144% above its 2-year average of -30.02%, near the high end of its 2-year range (-70.93%–13.18%).
136.26% above its 12-month average of -36.35%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): 5.28%.
RETURN ON ASSETS (ROA)
13.18%
RETURN ON ASSETS (ROA) AVG TTM
-36.35%
RETURN ON ASSETS (ROA) AVG 3Y
N/A
RETURN ON ASSETS (ROA) AVG 5Y
N/A
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+136.26%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.94%
median of 102 covered companies
CURRENT VS SECTOR MEDIAN
+166.80%
vs the sector median at left
Hinge Health, Inc.
Market Cap
$7.56B
Return on Assets (ROA)
13.18%
TTM Avg
-36.35%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$8.02B
Return on Assets (ROA)
4.91%
TTM Avg
-3.24%
3Y Avg
-6.85%
5Y Avg
-10.42%
Market Cap
$6.63B
Return on Assets (ROA)
17.41%
TTM Avg
17.14%
3Y Avg
16.98%
5Y Avg
18.36%
Market Cap
$6.47B
Return on Assets (ROA)
-3.91%
TTM Avg
11.88%
3Y Avg
0.12%
5Y Avg
-6.73%
Market Cap
$9.12B
Return on Assets (ROA)
11.86%
TTM Avg
10.65%
3Y Avg
7.37%
5Y Avg
5.11%
Market Cap
$5.61B
Return on Assets (ROA)
-78.04%
TTM Avg
-72.67%
3Y Avg
-59.05%
5Y Avg
-50.29%
Market Cap
$9.67B
Return on Assets (ROA)
3.54%
TTM Avg
3.68%
3Y Avg
4.39%
5Y Avg
5.01%
Market Cap
$5.35B
Return on Assets (ROA)
-17.02%
TTM Avg
-21.01%
3Y Avg
-19.47%
5Y Avg
-13.88%
Market Cap
$5.22B
Return on Assets (ROA)
15.41%
TTM Avg
17.55%
3Y Avg
14.67%
5Y Avg
15.71%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Hinge Health, Inc. (HNGE) | $7.56B | 13.18% | -36.35% | N/A | N/A |
| Oscar Health, Inc. (OSCR)vs › | $8.02B | 4.91% | -3.24% | -6.85% | -10.42% |
| Chemed Corporation (CHE)vs › | $6.63B | 17.41% | 17.14% | 16.98% | 18.36% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.47B | -3.91% | 11.88% | 0.12% | -6.73% |
| Insulet Corp. (PODD)vs › | $9.12B | 11.86% | 10.65% | 7.37% | 5.11% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.61B | -78.04% | -72.67% | -59.05% | -50.29% |
| Henry Schein, Inc. (HSIC)vs › | $9.67B | 3.54% | 3.68% | 4.39% | 5.01% |
| CRISPR Therapeutics AG (CRSP)vs › | $5.35B | -17.02% | -21.01% | -19.47% | -13.88% |
| Doximity, Inc. (DOCS)vs › | $5.22B | 15.41% | 17.55% | 14.67% | 15.71% |
| Molina Healthcare, Inc. (MOH)vs › | $9.89B | -0.04% | 5.29% | 6.08% | 6.13% |
ROA
13.2%
ROE
31.7%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -70.93% |
| 2024-12-31 | -1.77% |
| 2023-12-31 | -17.37% |
